GH
Guardant Health, Inc.
Stock
$177.80+3.05 (+1.75%)Close Oct 2, 2026
- Research and development, 2025
- $364M
- YoY, 2025
- +4.7%
- 5-year CAGR
- +19.4%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $364M | +4.7% |
| 2024 | $348M | −5.3% |
| 2023 | $367M | −1.8% |
| 2022 | $374M | +42.0% |
| 2021 | $263M | +75.6% |
| 2020 | $150M | +73.7% |
| 2019 | $86M | +70.2% |
| 2018 | $51M | +98.4% |
| 2017 | $26M | +135.4% |
| 2016 | $11M | — |